Iga Swiatek’s recent positive doping test for the banned substance Trimetazidine has sparked discussions on the fairness of doping procedures in tennis. Former players like Nick Kyrgios and Simona Halep have voiced concerns about inconsistent treatment among athletes. The International Tennis Integrity Agency (ITIA) is under scrutiny, while Swiatek, a five-time Grand Slam champion, promises to address the incident transparently despite her withdrawal from upcoming tournaments. The case is now under review by the World Anti-Doping Agency (WADA).